Post-COVID-19 infections and evolution of pulmonary and cardiac lesions – the battle has just started

Mihălțan, Florin; Constantin, Ancuța

doi:10.2478/pneum-2021-0001

Abstract

Talking only about the acute phase of COVID-19 infection is not enough. A multitude of complications has arisen after viremia, which has been generating problems for experts. Of these, lung and heart lesions remain important, and interventions, and their prevalence pose real problems for practitioners. The authors analyze these post-COVID-19 complications as well as appropriate recommendations for diagnostic and therapeutic interventions

References

1. Ojo AS, Balogun SA, Williams OT, Ojo OS. Pulmonary fibrosis in COVID-19 survivors: Predictive factors and risk reduction strategies. Pulmonary Medicine. 2020;10. Available from: doi: 10.1155/2020/6175964.10.1155/2020/6175964743916032850151
Search in Google Scholar Back to article
2. Hui DS, Joynt GM, Wong KT, Gomersall CD, Li TS, Antonio G. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005;60(5): 401–409.10.1136/thx.2004.030205175890515860716
Search in Google Scholar Back to article
3. NHS England. Aftercare needs of inpatients recovering from COVID-19. Jun 2020. Available from: https://www.england.nhs.uk/coronavirus/publication/after-care-needs-of-inpatients-recoveringfrom-covid-19.
Search in Google Scholar Back to article
4. Zhang P, Li J, Liu H, Han N, Ju J, Kou Y, et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Research. 2020;8: 8.10.1038/s41413-020-0084-5701871732128276
Search in Google Scholar Back to article
5. Chen J, Wu J, Hao S, Yang M, Lu X, Chen X, et al. Long term outcomes in survivors of epidemic influenza A (H7N9) virus infection. Scientific Reports. 2017;7: 17275.10.1038/s41598-017-17497-6572286129222500
Search in Google Scholar Back to article
6. Zuo W, Zhao X, Chen YG. SARS Coronavirus and lung fibrosis. Molecular biology of the SARS-Coronavirus. 2009;247–258. Published 2009 Jul 22. Available from: doi: 10.1007/978-3-642-03683-5_15.10.1007/978-3-642-03683-5_15
Search in Google Scholar Back to article
7. Ioshi A. Long term complications associated with Covid-19: a review. International Journal of Innovative Science and Research Technology 2020;5(9): 324–326.10.38124/IJISRT20SEP144
Search in Google Scholar Back to article
8. TOI STAFF-(Akiko Iwasaki, a professor of immunobiology at Yale interview)- ‘Long COVID’ may be caused by body attacking itself, not the virus – study-14 December 2020, The Times from Israel.
Search in Google Scholar Back to article
9. Potus F, Mai V, Lebret M, Malenfant S, Breton-Gagnon E, Lajoie AC. Novel insights on the pulmonary vascular consequences of COVID-19. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2020;319(2): L277–L288.10.1152/ajplung.00195.2020741423732551862
Search in Google Scholar Back to article
10. Geddes L. Why strange and debilitating coronavirus symptoms can last for months. Scientist 2020. Available from: https://www.newscientist.com/article/mg24632881-400-why-strange-and-debilitatingcoronavirus-symptoms-can-last-for-months/.
Search in Google Scholar Back to article
11. Ding X, Xu J, Zhou J, Long Q. Chest CT findings of COVID-19 pneumonia by duration of symptoms. European Journal of Radiology. 2020;127: 109009. Available from: doi: 10.1016/j. ejrad.2020.10900 910.1016/j.ejrad.2020.109009
Search in Google Scholar Back to article
12. COVID Symptom Study. How long does COVID-19 last? Kings College London; 2020. Available from https://covid19.joinzoe.com/post/covid-long-term?fbclid=IwAR1RxIcmmdL-EFjh_aI-.
Search in Google Scholar Back to article
13. Tian S, Xiong Y, Liu H, Niu L, Guo J, Liao M, et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Modern Pathology. 2020. Available from: doi: 10.1038/s41379-020-0536-x.10.1038/s41379-020-0536-x715623132291399
Search in Google Scholar Back to article
14. Marchiori E, Hochhegger B, Zanetti G. Organising pneumonia as a late abnormality in influenza A (H1N1) virus infection. The British Journal of Radiology. 2012;85: 841; author reply 842.10.1259/bjr/91363092347412622665929
Search in Google Scholar Back to article
15. Ong K-C, Ng AW-K, Lee LS-U, Kaw G, Kwek S-K, Leow MK-S, et al. 1-year pulmonary function and health status in survivors of severe acute respiratory syndrome. Chest. 2005;128: 1393–1400.10.1378/chest.128.3.1393709473916162734
Search in Google Scholar Back to article
16. Kreuter M, Polke M, Walsh SL, Krisam J, Collard HR, Chaudhuri N, et al. Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonization. European Respiratory Journal. 2020;55(4): 1901760.10.1183/13993003.01760-2019
Search in Google Scholar Back to article
17. Cao Y, Liu X, Xiong L, Cai K. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis. Journal of Medical Virology. 2020. Available from: doi: 10.1002/jmv.25822.10.1002/jmv.25822
Search in Google Scholar Back to article
18. Huang Y, Tan C, Wu J, Chen M, Wang Z, Luo L, et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respiratory Research. 2020;21: 163. Available from: doi: 10.1186/s12931-020-01429-6.10.1186/s12931-020-01429-6
Search in Google Scholar Back to article
19. Hui DS, Wong KT, Ko FW, Tam LS, Chan DP, Woo J, et al. The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest. 2005;128(4): 2247–2261.10.1378/chest.128.4.2247
Search in Google Scholar Back to article
20. Zheng Z, Chen R, Wu H, Liu X, He W, Xu Y, et al. Changes in pulmonary function in severe acute respiratory syndrome patients during convalescent period. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2005;17(6): 329.
Search in Google Scholar Back to article
21. NGAI JC, Ko FW, Ng SS, To K-W, Tong M, Hui DS. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010;15(3): 543–550.10.1111/j.1440-1843.2010.01720.x
Search in Google Scholar Back to article
22. Zhao YM, Shang YM, Song WB, Li Q-Q, Xie H, Xu QF, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. E ClinicalMedicine. 2020;25: 100463. Available from: doi: 10.1016/j.eclinm.2020.100463.10.1016/j.eclinm.2020.100463
Search in Google Scholar Back to article
23. Ahmed H, Patel K, Greenwood D, Halpin St., Lewthwaite P, Salawu A, et al. Long-term clinical outcomes in survivors of coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis of follow-up studies. medRxiv. 2020.04.16.20067975; Available from: doi: 10.1101/2020.04.16.20067975.10.1101/2020.04.16.20067975
Search in Google Scholar Back to article
24. Cardinal-Fernández P, Lorente JA, Ballén-Barragán A, Matute-Bello G. Acute respiratory distress syndrome and diffuse alveolar damage. New insights on a complex relationship. Annals of the American Thoracic Society. 2017;14: 844–850.10.1513/AnnalsATS.201609-728PS
Search in Google Scholar Back to article
25. Kumar Rai D, Sharma P, Kumar R. Post covid 19 pulmonary fibrosis- Is it reversible? Indian Journal of Tuberculosis, 2020, Available from: doi: 10.1016/j.ijtb.2020.11.003. Available from: http://www.sciencedirect.com/science/article/pii/S0019570720302134.
Search in Google Scholar Back to article
26. Spagnolo P, Balestro E, Aliberti S, Cocconcelli E, Biondini D, Casa GD, et al. Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respiratory Medicine. 2020;8(8): 750–752.10.1016/S2213-2600(20)30222-8
Search in Google Scholar Back to article
27. Leung TYM, Chan AYL, Chan EW, Chan VKY, Chui CSL, Cowling BJ, et al. Short- and potential long-term adverse health outcomes of COVID-19: a rapid review. Emerging Microbes & Infections. 2020;9(1): 2190–2199.10.1080/22221751.2020.1825914758644632940572
Search in Google Scholar Back to article
28. Carfì A, Bernabei R, Landi F, for the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6): 603–605.10.1001/jama.2020.12603734909632644129
Search in Google Scholar Back to article
29. Tenforde MW, Kim SS, Lindsell CJ, Rose EB., Shapiro NI, Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network — United States, March–June 2020. Morbidity and Mortality Weekly Report. 2020;69: 993–998.10.15585/mmwr.mm6930e1739239332730238
Search in Google Scholar Back to article
30. Lam MH-B, Wing Y-K, Yu MW-M, Leung C-M, Ma RCW, Kong APS, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term Follow-up. Archives of Internal Medicine. 2009;169(22): 2142–2147.10.1001/archinternmed.2009.38420008700
Search in Google Scholar Back to article
31. Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, et al. Rodriguez-Morales Coronavirus Disease 2019–COVID-19. Available from: doi: 10.1128/CMR.00028-20.10.1128/CMR.00028-20740583632580969
Search in Google Scholar Back to article
32. Fraser E. Long term respiratory complications of covid-19. BMJ. 2020;370: m3001. Available from: doi: 10.1136/bmj.m3001 (Published 03 August 2020.10.1136/bmj.m300132747332
Search in Google Scholar Back to article
33. Assaf G, Davis H, McCorkell L, Wei H, Brooke O, Akrami A, et al. An analysis of the prolonged COVID-19 symptoms survey by Patient-Led Research Team. Patient Led Research, 2020. Available from: https://patientresearchcovid19.com/.
Search in Google Scholar Back to article
34. Larun L, Brurberg KG, Odgaard-Jensen J, Price JR. Exercise therapy for chronic fatigue syndrome. Cochrane Database of Systematic Reviews. 2017;4: PMID: 28444695.10.1002/14651858.CD003200.pub7641952428444695
Search in Google Scholar Back to article
35. Trisha G, Matthew K, Christine A’C, Maria B, Laiba H. Management of post-acute covid-19 in primary care. BMJ. 2020;370: m3026.10.1136/bmj.m302632784198
Search in Google Scholar Back to article
36. Homerton University Hospital. Post COVID-19 patient information pack. 2020. Available from: https://www.hackneycitizen.co.uk/wp-content/uploads/Post-COVID-19-information-pack5.pdf.
Search in Google Scholar Back to article
37. O’Driscoll BR, Howard LS, Earis J, Mak V; British Thoracic Society Emergency Oxygen Guideline Group; BTS Emergency Oxygen Guideline Development Group. BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax. 2017;72(Suppl 1): ii1-90.10.1136/thoraxjnl-2016-20972928507176
Search in Google Scholar Back to article
38. National Institute for Health and Care Excellence. Statement about graded exercise therapy in the context of COVID-19. In: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (in development GID-NG10091). 2020. Available from: http://www.nice.org.uk/guidance/gid-ng10091/documents/statement.
Search in Google Scholar Back to article
39. Hoffman GJ, Webster NJ, Bynum JPW. A framework for aging-friendly services and supports in the age of COVID-19. Journal of Aging & Social Policy. 2020;32: 450–459.10.1080/08959420.2020.177123932441572
Search in Google Scholar Back to article
40. Mitrani RD, Dabas N, Goldberger JJ. COVID-19 cardiac injury: implications for long-term surveillance and outcomes in survivors. 2020;17(11): 1984–1990. Available from: doi: 10.1016/J. HRTHM.2020.06.0 26.
Search in Google Scholar Back to article
41. Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. European Journal of Clinical Investigation. 2009;39(7): 618–625. Available from: doi: 10.1111/j.1365-2362.2009.02153.x.10.1111/j.1365-2362.2009.02153.x716376619453650
Search in Google Scholar Back to article
42. Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging (MRI) in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiology. 2020;5(11): 1265–1273.10.1001/jamacardio.2020.3557
Search in Google Scholar Back to article
43. Yancy CW, Fonarow GC. Coronavirus disease 2019 (COVID-19) and the heart – is heart failure the next chapter? JAMA Cardiology. 2020;5(11): 1216–1217.10.1001/jamacardio.2020.3575
Search in Google Scholar Back to article
44. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiology. 2020;5(7): 811–818.10.1001/jamacardio.2020.1017
Search in Google Scholar Back to article
45. Chang J-J, Lin M-S, Chen T-H, Chen D-Y, Chen S-W, Hsu J-T, et al. Heart failure and mortality of adult survivors from acute myocarditis requiring intensive care treatment – a Nationwide Cohort Study. International Journal of Medical Sciences. 2017;14: 1241–1250.10.7150/ijms.20618
Search in Google Scholar Back to article
46. Mitrani RD, Abas N, Goldberger JJ. COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors. Heart Rhythm. 2020;17: 1984–1990.10.1016/j.hrthm.2020.06.026
Search in Google Scholar Back to article
47. Andrejak C, Cottin V, Crestani B, Debieuvre D, Bermejo J-G, Panzini CM, et al. Guide de prise en charge des séquelles respiratoires post infection à SARS-CoV-2. Propositions de prise en charge élaborées par la Société de Pneumologie de Langue Francaise. Version du 10 novembre 2020. Revue des Maladies Respiratoires. 2020, Available from: doi: 10.1016/j. rmr.2020.11.009.10.1016/j.rmr.2020.11.009
Search in Google Scholar Back to article
48. Horby P, Lim WS, Emberson J, Mafham M, Bell J, Linsell L, et al. Effect of dexamethasone in hospitalized patients with covid-19: preliminary report. MedRxiv 20202020.2006.2022.20137273 [Preprint]. Available from: https://www.medrxiv.org/content/10.1101/2020.06.22.20137273v1.
Search in Google Scholar Back to article
49. George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. The Lancet Respiratory Medicine. 2020;8(8): P507–P515. Available from: doi: 10.1016/S2213-2600(20)30225-3.10.1016/S2213-2600(20)30225-3
Search in Google Scholar Back to article
50. British Thoracic Society. Guidance on respiratory follow up of patients with a clinico-radiological diagnosis of covid-19 pneumonia. 2020. Available from: www.brit-thoracic.org.uk.
Search in Google Scholar Back to article
51. del Rio C, Collins LF, Malani P. Long-term Health Consequences of COVID-19. JAMA. 2020;324(17): 1723–1724.10.1001/jama.2020.19719
Search in Google Scholar Back to article
52. Yelin D, Wirtheim E, Vetter P, Kalil AC, Bruchfeld J, Runold M, et al. Long-term consequences of COVID-19: research needs. Lancet Infectious Diseases. 2020;20(10): 1115–1117.10.1016/S1473-3099(20)30701-5
Search in Google Scholar Back to article

Post-COVID-19 infections and evolution of pulmonary and cardiac lesions – the battle has just started

Abstract

Paradigm

My account